Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluation. (Q34045477)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluation.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21985636%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluation (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21985636%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

(E)-phytonadione

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21985636%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21985636%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Hyun-Mi Bae

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21985636%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Jeong-Hoon Lee

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21985636%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Dae Seog Heo

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21985636%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Hyo-Suk Lee

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21985636%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

language of work or name

0 references

publication date

10 October 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21985636%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21985636%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21985636%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

435

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21985636%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

https://scigraph.springernature.com/pub.10.1186/1471-2407-11-435

0 references

Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3210108

5 July 2018

Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3210108

5 July 2018

Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3210108

5 July 2018

A decade's studies on metastasis of hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3210108

5 July 2018

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3210108

5 July 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3210108

5 July 2018

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3210108

5 July 2018

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3210108

5 July 2018

Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3210108

5 July 2018

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3210108

5 July 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3210108

5 July 2018

Surgery for small liver cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3210108

5 July 2018

Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative des-gamma-carboxy prothrombin value.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-435

21 January 2018

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-435

21 January 2018

Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-435

21 January 2018

Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments

1 reference

https://pubmed.ncbi.nlm.nih.gov/21985636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21985636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simplified staging for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21985636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatectomy with an ultrasonic dissector for hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21985636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21985636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21985636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum and tissue PIVKA-II expression reflect the biological malignant potential of small hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21985636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of sorafenib in patients with advanced hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21985636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/21985636

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-11-435

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21985636%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21985636%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21985636%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34045477&oldid=1588394588"